Bone Biologics Corp Files 8-K
Ticker: BBLGW · Form: 8-K · Filed: Sep 4, 2025 · CIK: 1419554
| Field | Detail |
|---|---|
| Company | Bone Biologics Corp (BBLGW) |
| Form Type | 8-K |
| Filed Date | Sep 4, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-filing, medical-devices
Related Tickers: BBLG
TL;DR
Bone Biologics (BBLG) filed an 8-K on 9/4/25, confirming its business in orthopedic supplies.
AI Summary
Bone Biologics Corporation filed an 8-K on September 4, 2025, reporting current information. The filing indicates the company's primary business is in orthopedic, prosthetic, and surgical appliances and supplies. The company is incorporated in Delaware and its fiscal year ends on December 31.
Why It Matters
This 8-K filing provides a routine update on Bone Biologics Corporation's corporate status and business sector, which is relevant for investors tracking the company's regulatory compliance and industry classification.
Risk Assessment
Risk Level: low — This filing is a standard 8-K for current reporting and does not contain any new material financial events or significant strategic changes.
Key Numbers
- 001-40899 — SEC File Number (Identifies the company's filing with the SEC)
- 1231 — Fiscal Year End (Indicates the end of the company's financial reporting year)
Key Players & Entities
- Bone Biologics Corporation (company) — Registrant
- September 4, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 3842 (sic_code) — Standard Industrial Classification
- 421743430 (ein) — Employer Identification Number
FAQ
What is the primary business of Bone Biologics Corporation?
Bone Biologics Corporation's primary business is in the sector of Orthopedic, Prosthetic & Surgical Appliances & Supplies, as indicated by its Standard Industrial Classification code 3842.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on September 4, 2025.
In which state is Bone Biologics Corporation incorporated?
Bone Biologics Corporation is incorporated in Delaware.
What is the SEC file number for Bone Biologics Corporation?
The SEC file number for Bone Biologics Corporation is 001-40899.
What is the Employer Identification Number (EIN) for Bone Biologics Corporation?
The Employer Identification Number (EIN) for Bone Biologics Corporation is 421743430.
Filing Stats: 435 words · 2 min read · ~1 pages · Grade level 12.1 · Accepted 2025-09-04 07:05:25
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share BBLG Nasdaq Capital Marke
Filing Documents
- form8-k.htm (8-K) — 46KB
- ex99-1.htm (EX-99.1) — 24KB
- ex99-1_001.jpg (GRAPHIC) — 5KB
- 0001493152-25-012604.txt ( ) — 288KB
- bblg-20250904.xsd (EX-101.SCH) — 4KB
- bblg-20250904_def.xml (EX-101.DEF) — 26KB
- bblg-20250904_lab.xml (EX-101.LAB) — 36KB
- bblg-20250904_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BONE BIOLOGICS CORPORATION Date: September 4, 2025 By: /s/ Jeffrey Frelick Jeffrey Frelick Chief Executive Officer